Mayne Pharma Group Limited (ASX:MYX)
Australia · Delayed Price · Currency is AUD 5.05
+0.20 (4.12%)
Nov 6, 2025, 4:18 PM AEST
Mayne Pharma Group Market Cap
Mayne Pharma Group has a market cap or net worth of 410.29 million as of November 6, 2025. Its market cap has increased by 6.99% in one year.
Market Cap
410.29M
Enterprise Value
351.16M
Revenue
408.10M
Ranking
n/a
PE Ratio
n/a
Stock Price
5.05
Market Cap Chart
Since June 29, 2007, Mayne Pharma Group's market cap has increased from 45.66M to 410.29M, an increase of 798.59%. That is a compound annual growth rate of 12.70%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 6, 2025 | 410.29M | 1.61% |
| Dec 31, 2024 | 403.79M | -19.19% |
| Dec 29, 2023 | 499.66M | 43.60% |
| Dec 30, 2022 | 347.96M | -33.16% |
| Dec 31, 2021 | 520.63M | -10.12% |
| Dec 31, 2020 | 579.28M | -20.69% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 85.54B |
| Pro Medicus | 26.99B |
| Cochlear | 18.36B |
| Sonic Healthcare | 10.27B |
| Ramsay Health Care | 7.22B |
| Telix Pharmaceuticals | 5.33B |
| Ansell | 5.16B |
| Mesoblast | 3.09B |